Form D · Biotechnology
PinkDx, Inc.
Indianapolis, IN · CIK 0001997642
Offering snapshot reported Oct 20, 2023 · SEC filing
- Reported sold
- $17M Offering amount: $40M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $245K Reported outside-investor minimum
- First sale
- Sep 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 20, 2023 | Initial | $16,984,994 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495343
Source: Form D, filed Oct 20, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bonnie Anderson | Executive |
| Joe C Cook, Iii | Director |
| Giulia C Kennedy | Executive |
| Timothy Mc Meekan | Director |
| Isaac Ro | Director |
| Risa Stack | Director |
| Eric Wang | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Indiana Square Suite 3500
Indianapolis, IN, 46204
Indianapolis, IN, 46204